Analystreport

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report